The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
加入 April 2007
1.1K 正在关注 22.3M 粉丝
Blackstone Life Sciences agreed to pay up to $1.5 billion to help Pfizer develop a GLP-1 receptor called berobenatide, an investigational drug being studied for chronic weight management and obesity-related conditions.
显示更多
